1007 Roche Enterprise
BioCentury & Getty Images


Roche deal for CF program brings return to Enterprise’s syndicate without full takeout

U.K. biotech sells one ion channel program, keeps another

Oct 7, 2020 | 10:14 PM GMT

Roche’s deal to acquire a clinical cystic fibrosis program from U.K.-based Enterprise delivers a return to the biotech’s shareholders while

Read the full 538 word article

How to gain access

Continue reading with a
two-week free trial.